Artūras Bortkevičius is a Management Board Chair and CEO at Ignitis.

In recent years, Artūras Bortkevičius has held the position of Chief Financial Officer of the international pharmaceutical company Sandoz Pharmaceuticals in the Baltic States. He also worked as a financial expert for the consulting company Frauditoriai and was the Financial Director of the Danish Royal Unibrew group company Ceres S.P.A. He also gained experience in Kalnapilis-Tauras Group and Sicor Biotech.

Tadas Adomaitis is a Member of the Supervisory Board since 8 June 2022.

He is also a Member of the Management Board and Chief Wholesale Officer at Ignitis, and a Member of the Management Board of Ignitis Suomi Oy.

Tadas Adomaitis started his career in the energy sector in 2007. In 2012, he started working for Klaipedos Nafta, where he contributed to the development of the LNG terminal project, and, since 2013, he has become the Commercial Director of the designated supplier LITGAS. Later, he worked for more than two years as the Director of the Customer Portfolio Management Department of Energijos Tiekimas. In 2018 he became the Head of LITGAS, and when the company was merged with Lietuvos Energijos Tiekimas, he became the Director of the Supply Department.

Tadas Adomaitis studied at the Institute of International Relations and Political Science, Vilnius University and obtained a master's degree in Regional Policy in the European Studies programme. He later studied at the Stockholm School of Economics in Riga, Latvia, where he obtained a bachelor's degree in Economics and Business Administration. He also completed a training programme for members of the management board at the Baltic Institute of Corporate Governance.